Skip to content
Govbase
Govbase
Congress·In Committee·S. 3716

Senate Bill Would Narrow Rare Disease Drug Monopolies to Specific Approved Uses

RARE Act

about 2 months ago·View on Congress.gov

Legislative Progress

Senate
House
President
Law

Key Points

  • This bill changes how the government grants "exclusivity" to companies that make medicines for rare diseases. Currently, when a company gets a drug approved for a rare disease, they often get 7 years where no one else can sell a drug for that entire disease. This bill limits that protection to only the specific use the drug was approved for.
  • Patients with rare diseases could see more treatment options and lower costs. By narrowing the rules, other companies can bring different treatments for the same disease to market much faster instead of being blocked by a broad 7-year "monopoly" on the entire condition.
  • This plan aims to fix a problem where one company could stop others from helping patients, even if the new medicine works differently or treats a different part of the illness. It encourages more companies to research rare diseases by making sure one drug doesn't block all others.
  • These changes would apply to all rare disease drugs, regardless of when they were first approved or designated. This means even drugs currently on the market would have their protections narrowed to match their specific approved uses.
Healthcare

Impact Analysis

Personal Impact

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Milestones

2 milestones2 actions
Jan 28, 2026Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jan 28, 2026

Introduced in Senate

Related Bills

2 bills
H.R. 1262Related bill

Mikaela Naylon Give Kids a Chance Act

Dec 2 — Received in the Senate.

S. 891Related bill

Bipartisan Health Care Act

Mar 6 — Read twice and referred to the Committee on Finance.

Source Information

Document Type

Congressional Bill

Official Title

RARE Act

Bill NumberS 3716
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Analysis generated by AI. Always verify with official sources.